ABCL icon

AbCellera Biologics
ABCL

Overview Fund Trends Analyst Outlook Journalist POV

62 hedge funds and large institutions have $2.74B invested in AbCellera Biologics in 2020 Q4 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$776M
2
+$421M
3
+$338M
4
SM
SB Management
United Arab Emirates
+$272M
5
HMC
Harvard Management Company
Massachusetts
+$165M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$7.65M
27
$7.04M
28
$4.01M
29
$3.88M
30
$2.21M
31
$2.01M
32
$1.84M
33
$1.38M
34
$1.16M
35
$849K
36
$805K
37
$805K
38
$706K
39
$695K
40
$601K
41
$560K
42
$402K
43
$360K
44
$322K
45
$307K
46
$247K
47
$236K
48
$212K
49
$204K
50
$201K
1
2
3